What happens when the anti-infectives division is sold?

[anonymous]

It's not Pfizer...

So is the sale just rumor or is there anything concrete about it?????

 

[anonymous]

So is the sale just rumor or is there anything concrete about it?????

Holy shit. THERE IS NO BUYER. PERIOD.

The bullshit announcement about the strategic review was just that, BULLSHIT. Announcing that AI and WH is for sale? WTF it’s a publicly traded company in the United States of America.... EVERYTHING IS FOR SALE! It was a bullshit announcement.

 

[anonymous]

Hate to break it to you but we are DEFINITELY going to be off- loaded. Despite what we may have been led to believe, it's not a commercial operation integration: it's a products only deal. Details are being hammered out but the recent under performance of Avycaz and the lack of re-growth for Dalvance are causing concerns for the buyers. Timeline for announcing the sale and our layoff is 3 weeks. Happy job hunting.

 

[anonymous]

Who is buying the product line?

 

[anonymous]

How many people work totall in this division? I don’t think the lay off would happen to all but think they would cut some unless they already have a sales force?

 

[anonymous]

How many vacancies now in the division anyway? Whoever buys this dumpster fire sure isn't going to do it for the "highly trained and experienced hospital salesforce." Ha! Most were trained in the last month.

 

[anonymous]

And another week on the golf course goes by. No news, oh well I stepped my game up these last few months.

 

[anonymous]

Hate to break it to you but we are DEFINITELY going to be off- loaded. Despite what we may have been led to believe, it's not a commercial operation integration: it's a products only deal. Details are being hammered out but the recent under performance of Avycaz and the lack of re-growth for Dalvance are causing concerns for the buyers. Timeline for announcing the sale and our layoff is 3 weeks. Happy job hunting.

I agree- and I think it's Pfizer. They already own Avycaz worldwide since they bought AZs small molecule products in 2016, and they announced they are back in the antibiotic and hospital game last month. Bad thing for us is they have a structure in place- not good for those hoping to go with the products

 

[anonymous]

I agree- and I think it's Pfizer. They already own Avycaz worldwide since they bought AZs small molecule products in 2016, and they announced they are back in the antibiotic and hospital game last month. Bad thing for us is they have a structure in place- not good for those hoping to go with the products

LOL- All the so called experts saying this BU is sold. You would have heard about this in the press if there was an interested party coming after it. NO one has put a bid in for it at this point. Saunders is providing lip service by saying otherwise. Tepper just sold off a 8% of his AGN stake. He is tired of waiting for change since Saunders has flipped him off.

 

[anonymous]

LOL- All the so called experts saying this BU is sold. You would have heard about this in the press if there was an interested party coming after it. NO one has put a bid in for it at this point. Saunders is providing lip service by saying otherwise. Tepper just sold off a 8% of his AGN stake. He is tired of waiting for change since Saunders has flipped him off.

I'm not so sure that we'd hear anything about it. Nobody cares. Nobody's excited. A sale will do nothing for AGN nor for whomever the buyer is. It will literally be the most boring transition from The Street's perspective ever. It may even harm the purchaser. Look at what dummies at Merck did by buying Cubist. Now there's a transaction that someone ought to have lost a career over. Every abx startup right now is either funded by the government or by charitable grants. Have you ever seen a market so completely indifferent to new and amazing lifesaving and life enhancing products? Shit, pharmacy is downright hostile. So is at least half of the infectious disease community. Sad but true.

 

[anonymous]

I'm not so sure that we'd hear anything about it. Nobody cares. Nobody's excited. A sale will do nothing for AGN nor for whomever the buyer is. It will literally be the most boring transition from The Street's perspective ever. It may even harm the purchaser. Look at what dummies at Merck did by buying Cubist. Now there's a transaction that someone ought to have lost a career over. Every abx startup right now is either funded by the government or by charitable grants. Have you ever seen a market so completely indifferent to new and amazing lifesaving and life enhancing products? Shit, pharmacy is downright hostile. So is at least half of the infectious disease community. Sad but true.

Pretty much right on the money. Cubist did have a huge R&D department and all the fixed assets of a stand alone company, so our sale will be much smaller in size and scope (including downside risk) than the MRK/Cubist deal.

 

[anonymous]

this is brutal

 

[anonymous]

this is bs

 

[anonymous]

No buyer

 

[anonymous]

No buyer

Still no buyer??? Ugh!!! Come on already

 

[anonymous]

Anyone know by now who the buyer is? or this this is at all happening?

 

[anonymous]

Total BS they just want us to leave on our own.

 

[anonymous]

There is no fucking buyer... PERIOD.

 

[anonymous]

Longest, most dramatic sell-off in history

 

[anonymous]

Longest, most dramatic sell-off in history

There’s no drama. It’s the same old shit for years. That’s the complete opposite of drama. Drama is supposed to keep you on the edge of your seat and interested. Nobody is interested in what happens in or to this division, including a large number of people who work in it.